About this Research Topic
November is the Pancreatic Cancer Awareness Month and at Frontiers in Oncology we want to highlight the recent discoveries in the field and raise awareness of the importance of early diagnosis, multidisciplinary management, and technological innovation support. Additionally, we aim to emphasize the crucial role of early identification and the streamlining of patient pathways to enhance treatment outcomes and patient experiences.
Pancreatic cancer is characterized as a highly aggressive lethal malignant cancer which has a great risk of local invasion and metastasis and has become increasingly common. Although, there are treatment methods such as surgical treatment, radiation therapy, immunotherapy and chemotherapy, the overall survive rate and prognosis remain poor due to its typically asymptomatic progression until advanced stages. Therefore, more research is required to understand how to identify pancreatic cancer more effectively as well as further treatment options for patients.
Early identification of pancreatic cancer and streamlining patient pathways plays a vital role in the outcomes for patients. By focusing on earlier detection through screening methods and risk assessment tools, it is possible to diagnose the disease at an earlier and more treatable stage, thereby improving prognosis and the survival rate for patients. Streamlining patient pathways involves optimizing the process for each patient from diagnosis to treatment to ensure quicker access to necessary interventions. Furthermore, research studies and general awareness regarding the symptoms of pancreatic cancer are required to be widely distributed which will enable earlier diagnosis.
The aim of this Research Topic is to provide a comprehensive overview of the latest advancements in the treatment and management of pancreatic cancer. By bringing together cutting-edge research, expert opinions, and clinical insights, this Research Topic seeks to deepen the understanding of innovative therapeutic strategies and management approaches. We also wish to explore the area of streamlining patient pathways to understand how to improve patient outcomes. Topics of interest include precision medicine, novel drug development and immunotherapy as treatment options for pancreatic cancer patients as well as early detection and patient pathways. We welcome Original Research, Perspectives, Reviews, Methods, Mini Reviews, Opinions, Systematic Reviews, Clinical Trials, and Case Reports.
Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.
Pancreatic cancer is characterized as a highly aggressive lethal malignant cancer which has a great risk of local invasion and metastasis and has become increasingly common. Although, there are treatment methods such as surgical treatment, radiation therapy, immunotherapy and chemotherapy, the overall survive rate and prognosis remain poor due to its typically asymptomatic progression until advanced stages. Therefore, more research is required to understand how to identify pancreatic cancer more effectively as well as further treatment options for patients.
Early identification of pancreatic cancer and streamlining patient pathways plays a vital role in the outcomes for patients. By focusing on earlier detection through screening methods and risk assessment tools, it is possible to diagnose the disease at an earlier and more treatable stage, thereby improving prognosis and the survival rate for patients. Streamlining patient pathways involves optimizing the process for each patient from diagnosis to treatment to ensure quicker access to necessary interventions. Furthermore, research studies and general awareness regarding the symptoms of pancreatic cancer are required to be widely distributed which will enable earlier diagnosis.
The aim of this Research Topic is to provide a comprehensive overview of the latest advancements in the treatment and management of pancreatic cancer. By bringing together cutting-edge research, expert opinions, and clinical insights, this Research Topic seeks to deepen the understanding of innovative therapeutic strategies and management approaches. We also wish to explore the area of streamlining patient pathways to understand how to improve patient outcomes. Topics of interest include precision medicine, novel drug development and immunotherapy as treatment options for pancreatic cancer patients as well as early detection and patient pathways. We welcome Original Research, Perspectives, Reviews, Methods, Mini Reviews, Opinions, Systematic Reviews, Clinical Trials, and Case Reports.
Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.
Keywords: Pancreatic cancer, gastrointestinal cancer, oncology, cancer, targeted therapies, immunotherapy, precision medicine
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
